Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to TreatmentOA
Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to Treatment
Hexin Li;Jiahui Cai;Gang Zhao;Lihui Zou
Clinical Biobank,Beijing Hospital,National Center of Gerontology,National Health Commission,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,ChinaClinical Biobank,Beijing Hospital,National Center of Gerontology,National Health Commission,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,ChinaDepartment of General Surgery,Beijing Hospital,Beijing,ChinaNational Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,China
biomarkercancerdiagnosisextrachromosomal circular DNAtreatment
biomarkercancerdiagnosisextrachromosomal circular DNAtreatment
《肿瘤学创新（英文）》 2025 (5)
70-79,10
This study was supported by the National High Level Hospital Clinical Research Fund(Grants BJ-2024-095,BJ-2022-194,and BJ-2023-077)and the CAMS Innovation Fund for Medical Sciences(2021-I2M-1-050).
评论